Onconetix 已向美国证券交易委员会（SEC）提交文件，计划登记由特定售股股东转售高达1亿股普通股。此举旨在为股东提供流动性，并可能对市场供需格局产生一定影响。该申请文件标志着公司在资本运作方面迈出了重要一步。
Onconetix 已向美国证券交易委员会（SEC）提交文件，计划登记由特定售股股东转售高达1亿股普通股。此举旨在为股东提供流动性，并可能对市场供需格局产生一定影响。该申请文件标志着公司在资本运作方面迈出了重要一步。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.